scispace - formally typeset
D

Daniel Wenzel

Researcher at Austrian Academy of Sciences

Publications -  8
Citations -  4058

Daniel Wenzel is an academic researcher from Austrian Academy of Sciences. The author has contributed to research in topics: Genomic imprinting & Sensory neuron. The author has an hindex of 7, co-authored 8 publications receiving 3067 citations.

Papers
More filters
Journal ArticleDOI

Cerebral organoids model human brain development and microcephaly

TL;DR: A human pluripotent stem cell-derived three-dimensional organoid culture system that develops various discrete, although interdependent, brain regions that include a cerebral cortex containing progenitor populations that organize and produce mature cortical neuron subtypes is developed.
Journal ArticleDOI

The histone chaperone CAF-1 safeguards somatic cell identity

TL;DR: The findings reveal the histone chaperone CAF-1 to be a novel regulator of somatic cell identity during transcription-factor-induced cell-fate transitions and provide a potential strategy to modulate cellular plasticity in a regenerative setting.
Journal ArticleDOI

Mapping the mouse Allelome reveals tissue-specific regulation of allelic expression.

TL;DR: It is shown that cluster size varies dynamically during development and can be substantially larger than previously thought, with the Igf2r cluster extending over 10 Mb in placenta, and escape from X-inactivation is tissue-specific, with leg muscle showing an unexpectedly high rate of XCI escapers.
Journal ArticleDOI

Comparative glycoproteomics of stem cells identifies new players in ricin toxicity

TL;DR: A novel quantitative approach to identify intact glycopeptides from comparative proteomic data sets, allowing us not only to infer complex glycan structures but also to directly map them to sites within the associated proteins at the proteome scale.
Journal ArticleDOI

Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa

TL;DR: iPSCs derived from fibroblasts with mutant type VII collagen were genetically corrected and used as cell therapy in mice with recessive dystrophic epidermolysis bullosa, suggesting that RDEB skin could be effectively and safely repaired using iPSC-based cell therapy.